From: Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study
Baseline variables | Males (843 patients) | Females (320 patients) | ||||
---|---|---|---|---|---|---|
Atopic | Non-atopic | p. value | Atopic | Non-atopic | p. value | |
n = 181 | n = 662 | n = 32 | n = 288 | |||
Age, yr | 53.0 (48.0–58.0) | 54.0 (48.0–59.0) | 0.164 | 51.0 (46.0–58.7) | 52.0 (47.0–58.0) | 0.391 |
Height, cm | 176 (172–181) | 176 (171–180) | 0.403 | 165.5 (160.5–169.7) | 165 (160–169) | 0.494 |
Weight, kg | 80.0 (72.0–88.0) | 78.0 (70.0–85.0) | 0.017 | 64.0 (58.5–73.7) | 62.0 (55.0–70.0) | 0.206 |
BMI, kg/m 2 | 25.3 (23.5–27.5) | 24.8 (22.6–27.1) | 0.016 | 23.8 (21.8–25.9) | 22.9 (21.0–25.4) | 0.205 |
Underweight (<18.5) | 2 (1.1%) | 7 (1.1%) | 0 (0.0%) | 17 (5.9%) | ||
Normal weight (18.5–24.9) | 77 (42.5%) | 342 (51.7%) | 0.102# | 20 (62.5%) | 186 (64.6%) | 0.277# |
Overweight/Obese (≥25) | 101 (55.8%) | 312 (47.1%) | 12 (37.5%) | 84 (29.2%) | ||
Packyears of smoking | 40.0 (29.2–55.5) | 38.7 (28.5–50.0) | 0.288 | 32.5 (26.7–36.0) | 29.9 (21.3–39.0) | 0.462 |
FEV 1 , liter * | 2.7 (2.4–3.3) | 2.8 (2.3–3.2) | 0.680 | 2.1 (1.6–2.4) | 2.0 (1.7–2.4) | 0.904 |
FEV 1 % pred. * | 78.7 (69.4–87.0) | 79.3 (68.1–89.1) | 0.685 | 79.4 (63.6–89.2) | 80.8 (70.5–88.5) | 0.666 |
FEV 1 %FVC * | 63.9 (56.7–68.5) | 64.4 (58.1–68.7) | 0.443 | 66.4 (61.4–70.0) | 65.5 (60.9–70.4) | 0.823 |
Reversibility % pred. | 2.9 (0.8–5.2) | 2.8 (0.0–5.4) | 0.932 | 3.2 (0.3–7.6) | 2.9 (0.0–5.5) | 0.323 |
Total IgE, kU/l ** | 248.5 (84.0–617.2) | 37.0 (15.0–82.0) | <0.0001 | 161.0 (25.5–1373.0) | 28.0 (13.0–75.0) | 0.002 |